(Q40590486)

21 September 2017

ERK-1/2 activity is required for efficient RSV infection (English)

1 reference

respiratory syncytial virus

21 September 2017

0 references

modulation by host of viral process

0 references

author name string

Xiaoyuan Kong

1

1 reference

21 September 2017

Homero San Juan

2

1 reference

21 September 2017

Aruna Behera

3

1 reference

21 September 2017

Mark E Peeples

4

1 reference

21 September 2017

Jerry Wu

5

1 reference

21 September 2017

Richard F Lockey

6

1 reference

21 September 2017

Shyam S Mohapatra

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

559

1 reference

21 September 2017

1-3

1 reference

21 September 2017

33-38

1 reference

Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Respiratory syncytial virus infection activates STAT signaling in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Identification of contaminating adenovirus type 1 in the ATCC reference strain of respiratory syncytial virus A2 (VR-1302).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

LPS induction of I kappa B-alpha degradation and iNOS expression in a skin dendritic cell line is prevented by the janus kinase 2 inhibitor, Tyrphostin b42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Influenza-virus-induced signaling cascades: targets for antiviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

7 January 2021

The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

7 January 2021

Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

7 January 2021

Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900002-X

7 January 2021

10.1016/S0014-5793(04)00002-X

Identifiers

DOI

1 reference

21 September 2017

1 reference